Trial Profile
Real world study evaluating Ceftolozane/Tazobactam in a large database of US hospitals to better understand treatment patterns and associated outcomes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2018
Price :
$35
*
At a glance
- Drugs Ceftazidime/tazobactam (Primary)
- Indications Bacterial infections; Nosocomial infections
- Focus Therapeutic Use
- 18 Nov 2018 New trial record
- 07 Oct 2018 Results presented at the IDWeek 2018